Related Experiment Video
Updated: Aug 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to
J L Fleg1, B Rothfeld, S H Gottlieb
1Laboratory of Cardiovascular Science, National Institute on Aging, Baltimore, Maryland 21224.
Insights
Digoxin does not improve exercise capacity in patients with congestive heart failure. However, its effect on peak oxygen consumption was inversely related to baseline levels during placebo treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Digitalis glycosides have a long history of use in treating congestive heart failure (CHF).
- Their efficacy in improving exercise capacity in CHF patients remains debated due to study limitations.
Purpose of the Study:
- To investigate the effect of digoxin on exercise capacity in patients with chronic stable CHF.
- To examine objective measures of exercise performance and hemodynamic responses.
Main Methods:
- A randomized, double-blind, crossover study involving 10 ambulatory CHF patients.
- Patients received either digoxin or placebo for 4 weeks, followed by maximal treadmill exercise and cycle ergometry with radionuclide angiography.
Main Results:
- Digoxin did not significantly alter treadmill exercise duration or peak oxygen consumption compared to placebo.
- A significant inverse relationship was observed between the change in peak oxygen consumption with digoxin and baseline levels during placebo.
- Systolic blood pressure was higher during digoxin therapy, but heart rate, oxygen pulse, and ventilation were similar.
Conclusions:
- Digoxin therapy does not enhance overall exercise capacity in patients with mild to moderate systolic CHF.
- Individual patient responses to digoxin regarding peak oxygen consumption may vary based on baseline functional status.
Abstract:
Despite 200 years of use, the ability of digitalis glycosides to improve exercise capacity in patients with congestive heart failure remains controversial, partly because of imprecise end points and suboptimal study design. Therefore, this question was examined in 10 ambulatory patients (8 men and 2 women) aged 46 to 70 years (mean 57.8) in sinus rhythm with mild to moderate chronic stable congestive heart failure due to coronary artery disease and systolic left ventricular dysfunction (ejection fraction 32 +/- 12). All underwent maximal treadmill exercise with respiratory gas analysis and upright cycle ergometry with gated radionuclide angiography after 4 weeks of digoxin or placebo therapy, administered in a randomized double-blind crossover protocol. Neither treadmill exercise duration (7.7 +/- 2.3 versus 7.3 +/- 2.7 min) nor peak oxygen consumption (18.7 +/- 3.7 versus 18.4 +/- 5.4 ml/kg per min) differed between digoxin and placebo regimens. However, the change in peak oxygen consumption induced by digoxin was inversely related to the peak oxygen consumption during placebo therapy (r = -0.64, p less than 0.05). At maximal treadmill effort, heart rate (138 +/- 16 versus 141 +/- 21 beats/min), oxygen pulse (10.3 +/- 2.1 versus 9.9 +/- 2.2 ml/beat), ventilation (40.3 +/- 10.6 versus 42.0 +/- 10.8 liters/min) and ventilatory equivalent (29.4 +/- 4.8 versus 31.5 +/- 6.8) did not differ between digoxin and placebo treatment, although systolic blood pressure was higher during digoxin therapy (163.0 +/- 23.1 versus 153.2 +/- 25.3 mm Hg, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

